PTAB Reform Bill Won't Help Cut Drug Prices, Groups Say

Ten think tanks and consumer groups have lined up in opposition to a Senate bill that proposes substantial changes to how patent challenges operate at the Patent Trial and Appeal Board,...

Already a subscriber? Click here to view full article